Melanoma-Associated Antigen Expression in Lymphangioleiomyomatosis Renders Tumor Cells Susceptible to Cytotoxic T Cells
Authors:
- Ruedi K. BraunRBRuedi K. Braun
- Daniel F. DillingDDDaniel F. Dilling
- I. Caroline Le PooleIPI. Caroline Le Poole
- 1 December 2009
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 175 (6) , 2463-2472
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Physiological factors that regulate skin pigmentationBioFactors, 2009
- Estrogen promotes the survival and pulmonary metastasis of tuberin-null cellsProceedings of the National Academy of Sciences, 2009
- Lung Transplantation for Lymphangioleiomyomatosis: The French ExperienceTransplantation, 2008
- Sirolimus Amelioration of Clinical Symptoms of Recurrent Lymphangioleiomyomatosis After Living-donor Lobar Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Premelanosome Amyloid-like Fibrils Are Composed of Only Golgi-processed Forms of Pmel17 That Have Been Proteolytically Processed in EndosomesJournal of Biological Chemistry, 2008
- Role of tumor-associated macrophages in tumor progression and invasionCancer and Metastasis Reviews, 2006
- Therapeutic implications of autoimmune vitiligo T cellsAutoimmunity Reviews, 2006
- Optimization of a self antigen for presentation of multiple epitopes in cancer immunityJournal of Clinical Investigation, 2006
- Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma.Clinical Cancer Research, 2006